Geneos Wealth Management’s Immunogen Inc IMGN Stock Holding History

Geneos Wealth Management’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-300	Closed	-$4.76K	–	2194
2023 Q3	$4.76K	Hold	300	–	–	﹤0.01%	1758
2023 Q2	$5.66K	Buy	+300	New	+$3.54K	﹤0.01%	1711
2021 Q2	–	Sell	-229	Closed	-$1K	–	3167
2021 Q1	$1K	Buy	+229	New	+$1.87K	﹤0.01%	3087
2018 Q4	–	Sell	-164	Closed	-$1K	–	2504
2018 Q3	$1K	Hold	164	–	–	﹤0.01%	2387
2018 Q2	$1K	Hold	164	–	–	﹤0.01%	2236
2018 Q1	$1K	Hold	164	–	–	﹤0.01%	2145
2017 Q4	$1K	Hold	164	–	–	﹤0.01%	2147
2017 Q3	$1K	Buy	+164	New	+$1.09K	﹤0.01%	2097
2016 Q2	–	Sell	-150	Closed	-$1K	–	1863
2016 Q1	$1K	Buy	+150	New	+$1.27K	﹤0.01%	1768

Other funds holding IMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Geneos Wealth Management's IMGN Position: Q4 2023 in Review

Geneos Wealth Management sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 300 shares — an estimated $4.76K sold.

Geneos Wealth Management first reported a position in IMGN in Q1 2016 and held it in 9 quarters. The position peaked at $5.66K in Q2 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

Geneos Wealth Management reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
Geneos Wealth Management sold 300 Immunogen Inc shares in Q4 2023, an estimated $4.76K.
Geneos Wealth Management first reported a position in Immunogen Inc in Q1 2016 and held it in 9 quarters.
Geneos Wealth Management's Immunogen Inc position peaked at $5.66K in Q2 2023.
327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Geneos Wealth Management's 13F filing for Q4 2023, filed 26 Jan 2024.